Novartis CEO, Vas Narasimhan shares the Company’s strategy and growth update at the annual J.P. Morgan Healthcare Conference 2024.

This investor focussed presentation covers our,
Renewed focused strategy, as an innovative medicines company, centered around core therapeutic areas and technology platforms
Robust pipeline, streamlined in areas of high unmet need
Attractive growth prospects, including 2023 guidance raised 3 times
Leadership in ESG, with focus on creating value in innovation and access to medicines. an ESG leadership.

J.P. Morgan Healthcare Conference
Event Date: January 08, 2024
Novartis JPM HC 2024 Coverage: https://go.novartis.social/48vH5nQ
Investor Relations: https://go.novartis.social/3NZQpId

Investor Events: https://go.novartis.social/4aSWlwu
Novartis Strategy: https://go.novartis.social/3vur6rn

Disclaimer: J.P. Morgan Healthcare Conference live event contains forwardlooking statements. Such forwardlooking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: https://go.novartis.social/3O1KKkX

Learn more: https: https://go.novartis.social/48vH5nQ